S. Palmer

Increased risk for mental disorders and suicide during the COVID-19 pandemic: the position statement of the Section on Suicidology and Suicide Prevention of the European Psychiatric Association.

E. Baca-García, P. Osváth, J. Beezhold, 2021, GLOBAL PSYCHIATRY ARCHIVES.

Hearing the Suicidal Patient's Emotional Pain

C. Dunkley, A. Borthwick, D. Kingdon, 2017, Crisis.

Health-Related Quality of Life and Health Care Costs in Severe, Refractory Irritable Bowel Syndrome

D. Thompson, E. Guthrie, F. Creed, 2001, Annals of Internal Medicine.

Outcome in severe irritable bowel syndrome with and without accompanying depressive, panic and neurasthenic disorders.

N. Read, D. Thompson, E. Guthrie, 2005, The British journal of psychiatry : the journal of mental science.

The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome.

N. Read, D. Thompson, E. Guthrie, 2003, Gastroenterology.

Cost-effectiveness of brief psychodynamic-interpersonal therapy in high utilizers of psychiatric services.

E. Guthrie, F. Creed, B. Tomenson, 1999, Archives of general psychiatry.

The relationship between somatisation and outcome in patients with severe irritable bowel syndrome.

N. Read, D. Thompson, E. Guthrie, 2008, Journal of psychosomatic research.

The cost-effectiveness of psychotherapy and SSRI antidepressants for severe irritable bowel syndrome

N. Read, D. Thompson, E. Guthrie, 2001 .